A Chronicle Pharmabiz Special
May 23, 2002
Removal of non-tariff barriers critical to enhance intra-Asia pharma trade
Pharmaceutical trade amongst Asian countries has long been a story of gross underutilization owing to variety of restrictive policies pursued by the governments in the region. The policy of quantitati
Korean pharmaceutical market: An overview
In 1995, the total value of drug production in Korea crossed US$ 7.5 billion. The share of production of pharmaceuticals to the total manufacturing industry in Korea is about 7.3 per cent and this ind
Generic companies: The guys who rake gold?
With a large number of drugs are about to go off patent, the Asian countries suddenly seem to be eyeing the new goldmine - the global generics market. The increasing popularity of generic drugs stems
Indonesia: An ideal pharmaceutical trade partner for India?
Currently, the composition of the local pharmaceuticals market is shared by domestic companies and MNCs in the proportion of 60: 40 respectively. According to trade figures of the Central Bureau of St
Biomedical Sciences: Thrust area in Singapore vision of knowledge-based economy
The Biomedical Sciences industry has shown promising growth so far. The industry's manufacturing output grew by 2.1 percent from 1999, to S$6.4 billion and its value added grew by 2.7 percent to S$5.2
Taiwan: R&D in Chinese herbal medicine gaining momentum
The Taiwan pharmaceutical industry can be divided into makers of Chinese herbal medicines and those who concentrate on Western medicines. Each sector has its own supply sources, manufacturing processe